Calcimedica announces proposed public offering of common stock

La jolla, calif. , oct. 30, 2024 /prnewswire/ -- calcimedica, inc. ("calcimedica" or the "company") (nasdaq: calc), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium ("crac") channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that it has commenced an underwritten public offering of its shares of common stock.
CALC Ratings Summary
CALC Quant Ranking